Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recruiting × SCLC × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 1 1

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 147 Neoplasms 132 Leukemia, Myeloid, Acute 131 Neoplasm Metastasis 128 Breast Neoplasms 124 Colorectal Neoplasms 116 Recurrence 95 Ovarian Neoplasms 92 Pancreatic Neoplasms 76 Advanced Solid Tumor 73 Prostatic Neoplasms 70 Multiple Myeloma 65 Lung Neoplasms 64 Stomach Neoplasms 61 Squamous Cell Carcinoma of Head and Neck 61 Advanced Solid Tumors 59 Lymphoma, Non-Hodgkin 58 Triple Negative Breast Neoplasms 55 Carcinoma, Hepatocellular 54 Melanoma 53 Glioblastoma 51 Lymphoma 50 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Lymphoma, B-Cell 48 Endometrial Neoplasms 48 Myelodysplastic Syndromes 47 Glioma 43 Hematologic Neoplasms 41 Lymphoma, Large B-Cell, Diffuse 39 Carcinoma, Renal Cell 39

Interventions

atezolizumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06179069 2025-08-15

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡